Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Liaoning Kangboshi Pharmaceutical is a comprehensive pharmaceutical enterprise headquartered in the Benxi High-tech Industrial Development Zone, a major hub known as China's "Medicine Capital." The company integrates research, development, and large-scale manufacturing, focusing on a diverse portfolio that includes traditional Chinese medicines (TCM), chemical generic drugs, and health supplements. Its core product offerings target critical therapeutic areas such as cardiovascular health, respiratory infections, and digestive disorders. Operating modern, GMP-certified production lines, Liaoning Kangboshi produces various dosage forms including injections, capsules, and tablets to serve the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 辽宁康博士制药.